FREE Membership Sign in

MENU

JavaScript is disabled in your browser.

In order visualise this page, please follow these steps.

Association raises concerns about proposed patented medicine guidelines

Visibility360, PDF version to share

By Kate McCaffery | Oct. 21, 2022, 10:42 a.m.

Flash | PATENTED MEDICINE PRICES REVIEW BOARD (PMPRB) | Regulation | Compliance | Analytic | Medication

Photo: Freepik | aleksandarlittlewolf

Pharmaceutical association says draft guidelines will exacerbate an already unpredictable regulatory environment.

This article is reserved to PRO Level subscribers

Discover the PRO Level

Advertisement

The most popular in Health

Health and well-being: A gap between workers and employers

Research and Markets publishes global generic drug report

Institute examines government’s interest in portable health benefits plans

Make your business shine with Visibility360!

Get a PDF version to share in your networks.

I'm interested

Headlines

Regulators warn advisors and investors alike about targeted impersonation schemes

Actuaries’ association publishes resource for practitioners new to risk management

Assuris boosts policyholder protection levels

Advertisement

Related topics …

Flash

Regulators warn advisors and investors alike about targeted impersonation schemes

Assuris boosts policyholder protection levels

Manulife Investment Management share investment outlook

Conflicts of interest highlighted in British Columbia compliance review

PATENTED MEDICINE PRICES REVIEW BOARD (PMPRB)

Federal government appoints chair of patented medicine review board

Patented medicine costs published

New draft guidelines for medicines out for consultation

High-cost medicine continues to drive up drug plan costs

Regulation

Actuaries’ association publishes resource for practitioners new to risk management

Investment Funds Institute of Canada prepares for annual Operations Day

Researcher looks at the potential consequences of Bill C-228

Ontario regulator seeks applicants for investor advisory panel

Compliance

Underwriters call for a thoughtful approach to business tax and retirement fund changes

British Columbia consults on implementation of restricted licensing framework

Regulators reconsider climate disclosure requirements

Climate guideline affecting federally-regulated institutions published for comment

Analytic

Commissions advocate for artificial intelligence guardrails

Firms join forces to advocate for single digital identity

Canada Pension Plan annualized return hits 10 per cent over 10 years

Canadian Gen Z investors earlier to the investment game than their older cohorts

Medication

Prominent economist and policy expert discuss coming long term care concerns

Research and Markets publishes global generic drug report

Insurers’ association provides feedback on drug policy work

Manulife says economy is straining employee mental health and employer bottom lines